Clinical impact of early graft function in kidney transplant recipients on long-term dialysis: A retrospective cohort study

Table 2 Post-transplant clinical characteristics, median (25^th-75^th percentiles)

Variables	Group LTD (n = 28)	Group STD (n = 227)	P value1
Immunosuppression
Methylprednisolone (%)	96.4	94.3	1
Tacrolimus (%)	53.6	44.5	0.423
Cyclosporine (%)	46.4	55.5	0.423
Mycophenolate mofetil (%)	96.4	89.0	0.328
Mizoribine (%)	0	3.1	1
Everolimus (%)	3.6	7.9	0.704
Outcomes
Best S-Cr (mg/dL)	1.37 (1.18-2.04)	1.33 (1.02-1.55)	0.102
Acute rejection (%)	21.4	23.8	1
CMV infection (%)	42.9	25.1	0.069
Surgical complications (%)	14.3	15.0	1
Hypertension (%)	85.7	83.3	1
Diabetes mellitus (%)	14.3	27.8	0.172
Dyslipidemia (%)	46.4	59.4	0.225
Malignancy (%)	17.9	4.8	0.021
CVD event (%)	10.7	6.6	0.429

¹P values were calculated using the Mann-Whitney U test for continuous variables and the χ² test for categorical variables.

Best S-Cr: Lowest serum creatinine level within 3 months of transplantation; CMV: Cytomegalovirus; CVD: Cardiovascular disease; LTD: Long-term dialysis; STD: Short-term dialysis.